Molecular pathophysiology and targeted therapeutics for muscular dystrophy
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (9) , 465-470
- https://doi.org/10.1016/s0165-6147(00)01770-3
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- DystrophinopathiesPublished by Elsevier ,2015
- Alteration in Calcium Handling at the Subcellular Level inmdx MyotubesJournal of Biological Chemistry, 2001
- Expression Profiling in the Muscular DystrophiesThe Journal of cell biology, 2000
- Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophyProceedings of the National Academy of Sciences, 2000
- Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophyMagnetic Resonance in Medicine, 2000
- The serum nitric oxide levels in patients with Duchenne muscular dystrophyBrain & Development, 2000
- Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal DisruptionThe Journal of cell biology, 1997
- Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular DystrophyCell, 1997
- Dystrophin analysis in duchenne and becker muscular dystrophy carriers: Correlation with intracellular calcium and albuminAnnals of Neurology, 1990
- Studies of sarcolemmal integrity in myopathic muscleNeurology, 1978